SCHEMBL4764056

SCHEMBL4764056

Cn1ccc2ncnc(Oc3ccc(NC(N)=O)c(Cl)c3)c21

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDR P35968 20/20 0.73
FGFR1 P11362 3/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4278301 0.90 KDR (0.74) KDRFGFR1
SCHEMBL4286004 0.85 KDR (1.00) KDRFGFR1
SCHEMBL4287296 0.84 KDR (1.00) KDRFGFR1
SCHEMBL4291658 0.84 KDR (0.71) KDRFGFR1
SCHEMBL4432118 0.84 KDR (0.73) KDRFGFR1
SCHEMBL4292548 0.84 KDR (0.76) KDRFGFR1
SCHEMBL4282097 0.83 KDR (0.78) KDRFGFR1
SCHEMBL4279794 0.83 KDR (0.78) KDRFGFR1
SCHEMBL4287888 0.83 KDR (0.82) KDRFGFR1
SCHEMBL4283277 0.83 KDR (0.83) KDRFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904498-A1 FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2008-04-02 EP disclosed
WO-2007004749-A1 FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-11 WO disclosed